Biblio
Found 3 results
Filters: Keyword is Antibodies, Monoclonal [Clear All Filters]
Randomized Phase II Trial of Ficlatuzumab With or Without Cetuximab in Pan-Refractory, Recurrent/Metastatic Head and Neck Cancer.. J Clin Oncol. 41(22):3851-3862.
.
2023. Spontaneous Resolution of Cholesteatoma in a Patient on Long-Term Infliximab.. Ann Otol Rhinol Laryngol. 128(4):365-368.
.
2019. PD-1 Blockade Prevents the Development and Progression of Carcinogen-Induced Oral Premalignant Lesions.. Cancer Prev Res (Phila). 10(12):684-693.
.
2017.